Aclaris Therapeutics
Christopher Molineaux has served as Chairman of Aclaris’ board of directors since June 2019 and as a member of Aclaris’ board of directors since January 2014. Mr. Molineaux is President and Chief Executive Officer of Life Sciences Pennsylvania, formerly Pennsylvania Bio, a pharmaceutical and biotech industry advocacy organization. Before joining Life Sciences Pennsylvania in 2009, Mr. Molineaux served as Worldwide Vice President of Pharmaceutical Communications and Public Affairs for Johnson & Johnson. Mr. Molineaux previously served as Vice President for Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA) and held positions at the Federal Department of Health & Human Services and the White House. He received a Bachelor of Arts from the College of the Holy Cross.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Aclaris Therapeutics
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options.